Despite the high diagnostic performance of PET/CT with 68Ga-labeled PSMA radiotracers in patients with BCR of prostate cancer, a considerable proportion of negative findings has also been reported, particularly in patients with low PSA levels [11–14]. The gene discussed is BCR; the disease is prostate carcinoma.